Sign In
Buy CRL
$179.87
+5.08 (+2.91%)
At Close: Jun 03, 2026
Charles River (CRL) Benefits From Price Rise Amid FX Woe
09:47am, Tuesday, 20'th Dec 2022
Charles River's (CRL) RMS growth prospects are high, courtesy of accelerating growth for research model services and research models.
Charles River Laboratories International, Inc. (CRL) Q3 2022 Earnings Call Transcript
04:38pm, Wednesday, 02'nd Nov 2022
Charles River Laboratories International, Inc. (NYSE:CRL ) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Todd Spencer - VP, IR James Foster - Chairman, President &
Charles River (CRL) Q3 Earnings Top Estimates, Margins Dip
12:48pm, Wednesday, 02'nd Nov 2022
Headwinds associated with foreign exchange due to the strengthening of the U.S. dollar and interest expense due to a rising interest rate environment increase concerns for Charles River (CRL).
Why Charles River Laboratories Stock Is Jumping Today
12:18pm, Wednesday, 02'nd Nov 2022
Investors liked the company's Q3 update.
Charles River Laboratories (CRL) Tops Q3 Earnings and Revenue Estimates
09:48am, Wednesday, 02'nd Nov 2022
Charles River (CRL) delivered earnings and revenue surprises of 4.78% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Charles River Laboratories: Near-Term Headwinds Outweigh Long-Term Tailwinds
03:27pm, Tuesday, 18'th Oct 2022
Shares of Charles River have been hard hit by operational missteps, but shares are not cheap enough to buy yet. While its safety unit has done very well, its CDMO unit has been slow to build momentum
Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
04:30pm, Tuesday, 11'th Oct 2022
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
Charles River's (CRL) New Launch to Boost Gene Therapy Workflow
12:02pm, Tuesday, 11'th Oct 2022
Charles River's (CRL) latest product offering is expected to streamline the pathway to GMP AAV vector manufacturing without significant process development.
Charles River (CRL) Gains From Growing Demand Amid Macro Woes
02:18pm, Wednesday, 21'st Sep 2022
Charles River (CRL) continues to expect that the growth rate will approach 20% in the second half of 2022.
Charles River (CRL) to Support Cure AP-4's Clinical Trials
12:47pm, Monday, 12'th Sep 2022
Charles River's (CRL) manufacturing collaboration with Cure AP-4 will support the latter's Phase I/II gene therapy trials for a rare neurodegenerative disorder.
Charles River Laboratories: A 'Picks And Shovels' Biomedical Play, Now Attractively Priced
01:56am, Saturday, 10'th Sep 2022
Charles River Labs, or "CRL", provides critical discovery, clinical and safety services to nearly all biotech and pharma companies and has built a hard-earned reputation for quality. With rapid advanc
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
04:30pm, Thursday, 08'th Sep 2022
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories to Present at September Conferences
Why Is Charles River (CRL) Down 10.7% Since Last Earnings Report?
12:48pm, Friday, 02'nd Sep 2022
Charles River (CRL) reported earnings 30 days ago. What's next for the stock?
Charles River (CRL) Business Hurt by Macro and FX Headwinds
10:32am, Tuesday, 16'th Aug 2022
In Q2, the impact of foreign currency translation reduces Charles River's (CRL) reported revenue growth by 3.4%.
10 Growth Stocks Analysts Say You'll Be Glad You Bought
08:00am, Monday, 08'th Aug 2022
Keeping a list of S&P 500 growth stocks you'd like to own is a good idea. And it might pay off sooner than you think.
